Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies
- PMID: 19685085
- DOI: 10.1007/s00520-009-0711-6
Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies
Erratum in
- Support Care Cancer. 2010 Sep;18(9):1235-6
Abstract
Purpose: Probiotics are expected to be effective in prophylaxis of infection in cancer patient, since infections in neutropenics are mainly caused by endogenous flora through the intestinal mucosa. However, the experience with the use of probiotics in immunocompromised patients is limited, and precise fecal bacteria analysis has not been reported. The aim of the study was to evaluate the effects of the enteral administration of the probiotic, Bifidobacterium breve strain Yakult, on its ability to prevent infection, fecal micro flora, and intestinal environments in cancer patients on chemotherapy.
Methods: A placebo-controlled trial was performed at Juntendo University Hospital. Patients with malignancies admitted for chemotherapy (n = 42) were randomized into two groups receiving probiotic or placebo. The effects on infectious complications, natural killer cells, fecal micro flora, fecal organic acid concentrations, and fecal pH were studied.
Results: The frequency of fever and the use of intravenous antibiotics were lower in the probiotic group than the placebo group. The probiotic administration enhanced the habitation of anaerobes. Disruption of the intestinal microbiota after chemotherapy such as the increase in the population levels of Enterobacteriaceae was observed at more pronounced manner in the placebo group in comparison to the probiotic group. The concentrations of total organic acids were maintained most of the time at the normal level, which constantly maintained the pH below 7.0 only in the probiotic group.
Conclusion: These data, although based on a limited number of patients and samples, suggest that administration of B. breve strain Yakult could be an effective approach for achieving clinical benefits in immunocompromised hosts by improving their intestinal environments.
Similar articles
-
Intestinal Microbiota in Pediatric Surgical Cases Administered Bifidobacterium Breve: A Randomized Controlled Trial.J Pediatr Gastroenterol Nutr. 2016 Jul;63(1):46-50. doi: 10.1097/MPG.0000000000001140. J Pediatr Gastroenterol Nutr. 2016. PMID: 26859092 Clinical Trial.
-
Probiotics for the prevention of pediatric antibiotic-associated diarrhea.Cochrane Database Syst Rev. 2015 Dec 22;(12):CD004827. doi: 10.1002/14651858.CD004827.pub4. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2019 Apr 30;4:CD004827. doi: 10.1002/14651858.CD004827.pub5. PMID: 26695080 Updated. Review.
-
Modulatory effects of Bifidobacterium longum BB536 on defecation in elderly patients receiving enteral feeding.World J Gastroenterol. 2013;19(14):2162-70. doi: 10.3748/wjg.v19.i14.2162. World J Gastroenterol. 2013. PMID: 23599642 Free PMC article. Clinical Trial.
-
The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.J Clin Gastroenterol. 2012 Mar;46(3):220-7. doi: 10.1097/MCG.0b013e31823712b1. J Clin Gastroenterol. 2012. PMID: 22157240 Clinical Trial.
-
Beneficial microbes for premature infants, and children with malignancy undergoing chemotherapy.Benef Microbes. 2010 Nov;1(4):357-65. doi: 10.3920/BM2010.0035. Benef Microbes. 2010. PMID: 21831775 Review.
Cited by
-
Evaluation of Safety and Beneficial Health Effects of the Human-Milk Strain Bifidobacterium breve DSM32583: An Infant Pilot Trial.Nutrients. 2024 Apr 11;16(8):1134. doi: 10.3390/nu16081134. Nutrients. 2024. PMID: 38674825 Free PMC article. Clinical Trial.
-
Understanding the role of gut microfloral bifidobacterium in cancer and its potential therapeutic applications.Microbiome Res Rep. 2023 Oct 31;3(1):3. doi: 10.20517/mrr.2023.51. eCollection 2024. Microbiome Res Rep. 2023. PMID: 38455077 Free PMC article. Review.
-
The Hazards of Probiotics on Gut-Derived Pseudomonas aeruginosa Sepsis in Mice Undergoing Chemotherapy.Biomedicines. 2024 Jan 23;12(2):253. doi: 10.3390/biomedicines12020253. Biomedicines. 2024. PMID: 38397855 Free PMC article.
-
Development and management of gastrointestinal symptoms in long-term COVID-19.Front Microbiol. 2023 Dec 14;14:1278479. doi: 10.3389/fmicb.2023.1278479. eCollection 2023. Front Microbiol. 2023. PMID: 38156008 Free PMC article. Review.
-
Adverse Effect of the Duration of Antibiotic Use Prior to Immune Checkpoint Inhibitors on the Overall Survival of Patients with Recurrent Gynecologic Malignancies.Cancers (Basel). 2023 Dec 7;15(24):5745. doi: 10.3390/cancers15245745. Cancers (Basel). 2023. PMID: 38136291 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical